Literature DB >> 15655611

Survival after curative resection for rectal cancer by the end of the 20th century.

S Angelopoulos1, I Kanellos, N Sapidis, K Vasiliadis, A Kanellou, D Betsis.   

Abstract

BACKGROUND: The aim of this study was to define the survival rates in patients with rectal carcinoma treated with curative resections. PATIENTS AND METHODS: Between 1993 and 1998, 54 patients with rectal cancer underwent curative resection by conventional technique. Tumour location, TNM staging and tumour differentiation were evaluated. Among the 54 patients, 14 underwent high anterior resection, 28 low anterior resection, 7 abdominoperineal resection and 5 underwent local excision. Survival rates were calculated using the Kaplan-Meier method and long-range analysis.
RESULTS: Five-year survival was 70.4%. The survival rate statistically significantly decreased with increasing TNM tumour stage (p=0.009). Patients with poor differentiation of the tumour had the lowest 5-year survival (33%) compared to patients with moderate (72%) and good (78%) tumour differentiation. Sex and age did not affect survival. Location of the tumour in the distal end of the rectum and mucinous characteristics are poor prognostic factors affecting survival.
CONCLUSIONS: Curative resection combined with chemoradiotherapy, whenever necessary, is accompanied with acceptable 5-year survival rates.

Entities:  

Mesh:

Year:  2004        PMID: 15655611     DOI: 10.1007/s10151-004-0146-5

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  2 in total

1.  Anastomotic leakage after colonic resection.

Authors:  D Kanellos
Journal:  Tech Coloproctol       Date:  2010-11       Impact factor: 3.781

2.  Oncogramme, a new individualized tumor response testing method: application to colon cancer.

Authors:  Elodie Loum; Stephanie Giraud; Barbara Bessette; Serge Battu; Muriel Mathonnet; Christophe Lautrette
Journal:  Cytotechnology       Date:  2010-09-07       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.